Home/Filings/4/0001209191-19-048282
4//SEC Filing

Dempsey James F. 4

Accession 0001209191-19-048282

CIK 0001597313other

Filed

Sep 3, 8:00 PM ET

Accepted

Sep 4, 5:59 PM ET

Size

21.2 KB

Accession

0001209191-19-048282

Insider Transaction Report

Form 4
Period: 2019-09-03
Dempsey James F.
DirectorChief Scientific Officer
Transactions
  • Sale

    Common Stock

    2019-09-03$3.57/sh51,460$183,506220,973 total
  • Exercise/Conversion

    Common Stock

    2019-09-03$0.68/sh+164,697$111,994385,670 total
  • Sale

    Common Stock

    2019-09-03$3.57/sh164,697$587,310220,973 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2019-09-0351,4600 total
    Exercise: $0.68Exp: 2020-06-29Common Stock (61,752 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2019-09-0363,2570 total
    Exercise: $0.70Exp: 2022-03-01Common Stock (63,257 underlying)
  • Exercise/Conversion

    Common Stock

    2019-09-03$0.68/sh+51,460$34,993272,433 total
  • Exercise/Conversion

    Common Stock

    2019-09-03$0.70/sh+63,257$44,280284,230 total
  • Sale

    Common Stock

    2019-09-03$3.57/sh63,257$225,574220,973 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2019-09-03164,6970 total
    Exercise: $0.68Exp: 2020-06-29Common Stock (197,635 underlying)
Footnotes (6)
  • [F1]The transactions reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.42 to $3.94 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]Includes 38,371 shares granted as Restricted Stock Units. As of the transaction date, none of the restricted stock units have vested.
  • [F4]The shares subject to the option vested in 36 monthly installments beginning June 17, 2010 (the "Vesting Commencement Date") and became exercisable on each monthly anniversary thereafter, such that 100% of the shares subject to the option were fully vested on the 36 month anniversary of the Vesting Commencement Date.
  • [F5]The shares subject to the option vested in 48 monthly installments beginning July 14, 2010 (the "Vesting Commencement Date") and became exercisable on each monthly anniversary thereafter, such that 100% of the shares subject to the option were fully vested on the 48 month anniversary of the Vesting Commencement Date.
  • [F6]The shares subject to the option vested in 48 monthly installments beginning March 1, 2012 (the "Vesting Commencement Date") and became exercisable on each monthly anniversary thereafter, such that 100% of the shares subject to the option were fully vested on the 48 month anniversary of the Vesting Commencement Date.

Issuer

ViewRay, Inc.

CIK 0001597313

Entity typeother

Related Parties

1
  • filerCIK 0001637089

Filing Metadata

Form type
4
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 5:59 PM ET
Size
21.2 KB